BioNTech SE (BNTX) Current Taxes (2018 - 2025)
BioNTech SE (BNTX) posted Current Taxes of $76.4 million for Q4 2025, up 936.81% on a QoQ basis from $7.4 million in Q3 2025, and up 1487.99% year-over-year from $4.8 million in Q4 2024.
BioNTech SE (BNTX) has 7 years of Current Taxes data on file, last reported at $76.4 million in Q4 2025.
- In Q4 2025, Current Taxes rose 1487.99% year-over-year to $76.4 million; the TTM figure through Dec 2025 stood at $76.4 million (up 1487.99% YoY), while the FY2025 annual figure was $74.1 million, up 1441.29% from the prior year.
- Current Taxes rose to $76.4 million in Q4 2025, from $7.4 million in the prior quarter.
- Across five years, Current Taxes topped out at $1.8 billion in Q1 2022 and bottomed at $4.2 million in Q2 2025.
- A 5-year average of $629.2 million and a median of $565.2 million in 2023 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2024 — Current Taxes tumbled 99.15% — and 2025, when it surged 1487.99%.
- Year by year, Current Taxes stood at $1.8 billion in 2021, then sank by 66.13% to $608.0 million in 2022, then slipped by 7.0% to $565.4 million in 2023, then slumped by 99.15% to $4.8 million in 2024, then soared by 1487.99% to $76.4 million in 2025.
- The last three Current Taxes figures came in at $76.4 million (Q4 2025), $7.4 million (Q3 2025), and $4.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 76.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.36 Mn |
| Sep 30, 2025 | 7.37 Mn |
| Jun 30, 2025 | 4.19 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | 399.31 Mn |
| Jun 30, 2024 | 393.28 Mn |
| Mar 31, 2024 | 383.70 Mn |
| Dec 31, 2023 | 565.41 Mn |
| Sep 30, 2023 | 593.50 Mn |
| Jun 30, 2023 | 604.24 Mn |
| Mar 31, 2023 | 564.90 Mn |
| Dec 31, 2022 | 607.97 Mn |
| Sep 30, 2022 | 1.40 Bn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | 1.81 Bn |
| Dec 31, 2021 | 1.79 Bn |
| Mar 31, 2021 | 596.97 Mn |
| Dec 31, 2019 | 166,033.15 |
| Sep 30, 2019 | 330,480.82 |
| Dec 31, 2018 | 338,994.74 |